EPINEPHRINSPRÜHFORMULIERUNGEN
European patent · EP3612173 · Deleted
Register entry
- Publication number
- EP3612173
- Application number
- EP18786961
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Apr 17, 2018
- Published
- Feb 26, 2020
- Granted
- Oct 11, 2023
- Deleted
- Nov 23, 2024
- Reason
- Annual fee unpaid
- IPC classes
- A61K 9/08 (2006.01)A61K 47/18 (2017.01)A61K 47/02 (2006.01)A61K 47/10 (2017.01)A61K 31/137 (2006.01)A61P 37/08 (2006.01)
- Priority
- US 201715488712 17.04.2017
- PCT application
- PCT/US2018/027889 17.04.2018
- PCT publication
- WO2018/195029 25.10.2018
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Nov 23, 2024
Deleted, fee unpaid
- Status of protective title
- Active → Cancelled
- Cancellation date
- 23.11.2024
- Cause for cancellation
- Non-payment of renewal fee
Published in Swissreg on 23.11.2024
- Aug 21, 2024
Change
Published in Swissreg on 21.08.2024
- Dec 13, 2023
Owner
- Owner
- Hikma Pharmaceuticals USA Inc., 246 Industrial Way West, Eatontown, New Jersey 07724-2206, USA → Hikma Pharmaceuticals USA Inc., 200 Connell Drive, Berkeley Heights, NJ 07922, USA
Published in Swissreg on 13.12.2023
- Oct 11, 2023
Granted
Published in Swissreg on 11.10.2023
Parties
Inventor
CHILAMPALLI, Chandeshwari
Chandler AZ 85249, US
NARAYANAN, Eshwaran
Chandler AZ 85225, US
POTTA, Thrimoorthy
Phoenix AZ 85048, US
YAN, Ningxin
Chandler AZ 85249, US
INAVOLU, Rachana
Chandler AZ 85286, US
BASTIAN, Craig
Mesa AZ 85212, US
GOSKONDA, Venkat
Phoenix AZ 85044, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.